comparemela.com

Latest Breaking News On - Shankar musunuri - Page 25 : comparemela.com

Ocugen, Inc (OCGN) CEO Shankar Musunuri on Q1 2022 Results - Earnings Call Transcript

Ocugen, Inc. (NASDAQ:NASDAQ:OCGN) Q1 2022 Earnings Conference Call May 06, 2022 08:30 AM ET Company Participants Ken Inchausti - Head, Investor Relations & Communications Shankar.

United statesDaniel kathalynasSwayampakula ramakanthJessica crespoShankar musunuriKen inchaustiImran khanZegbeh jallahCompany participantsHealth net solutionsCommunications for ocugenInvestor relations communicationsWorld health organizationOcugen incWorld vaccine congressExchange commission

Ocugen Provides Business Update and First Quarter 2022 Financial Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesShankar musunuriMarnac whittingtonKen inchaustiCompany phaseCompany board of directorsDrug administrationInvestor relations communicationsOcugen incExchange commissionHealth canadaConference callWebcast todayChief executive officerSafety monitoring boardRights expanded

Ocugen, Inc (OCGN) Q1 2022 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2022.

United statesJess crespoJessica crespoShankar musunuriKen inchaustiZegbeh jallahExchange commissionWorld health organizationOcugen incWorld vaccine congressInvestor relationsRisk factorsChief executiveBharat biotechEmergency use authorizationAccounting afficer

Ocugen to commercialise Covaxin in Mexico

Ocugen to commercialise Covaxin in Mexico
daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshShankar musunuriKrishna ellaMarcelo ebrardForeign affairsOcugen incBharat biotechChief executive officerNorth americaManaging director

Ocugen, Inc to Present at NobleCon18

19.04.2022 - MALVERN, Pa., April 19, 2022 (GLOBE NEWSWIRE) - Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, today announces that Dr. Shankar Musunuri, .

United statesShankar musunuriHard rock hotel casinoOcugen incCapital market eighteenth annual investorRock hotelNoble capital market

vimarsana © 2020. All Rights Reserved.